List of Contents

AI In Revenue Cycle Management Market Size, Share, and Trends 2024 to 2034

AI in Revenue Cycle Management Market (By Type: Integrated, Standalone; By Component: Hardware, Software, Services; By Deployment Mode: Cloud, On-premises; By Application: Patient Scheduling, Eligibility and Benefits Verification, Patient Payment/Timing Estimation, Prior Authorization, Pre-billing Audits, Denials Management, Compliance Monitoring, Fraud Detection, Others; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034

  • Last Updated : October 2024
  • Report Code : 3305
  • Category : ICT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on AI in Revenue Cycle Management Market 

5.1. COVID-19 Landscape: AI in Revenue Cycle Management Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global AI in Revenue Cycle Management Market, By Type

8.1. AI in Revenue Cycle Management Market, by Type, 2024-2034

8.1.1. Integrated

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Standalone

8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global AI in Revenue Cycle Management Market, By Component

9.1. AI in Revenue Cycle Management Market, by Component, 2024-2034

9.1.1. Hardware

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Software

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Services

9.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global AI in Revenue Cycle Management Market, By Deployment Mode 

10.1. AI in Revenue Cycle Management Market, by Deployment Mode, 2024-2034

10.1.1. Cloud

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. On-premises

10.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global AI in Revenue Cycle Management Market, By Application

11.1. AI in Revenue Cycle Management Market, by Application, 2024-2034

11.1.1. Patient Scheduling

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Eligibility and Benefits Verification

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Patient Payment/Timing Estimation

11.1.3.1. Market Revenue and Forecast (2021-2034)

11.1.4. Prior Authorization

11.1.4.1. Market Revenue and Forecast (2021-2034)

11.1.5. Pre-billing Audits

11.1.5.1. Market Revenue and Forecast (2021-2034)

11.1.6. Denials Management

11.1.6.1. Market Revenue and Forecast (2021-2034)

11.1.7. Compliance Monitoring

11.1.7.1. Market Revenue and Forecast (2021-2034)

11.1.8. Fraud Detection

11.1.8.1. Market Revenue and Forecast (2021-2034)

11.1.9. Others

11.1.9.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global AI in Revenue Cycle Management Market, By End User

12.1. AI in Revenue Cycle Management Market, by End User, 2024-2034

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2021-2034)

12.1.2. Physicians

12.1.2.1. Market Revenue and Forecast (2021-2034)

12.1.3. Diagnostics Laboratories

12.1.3.1. Market Revenue and Forecast (2021-2034)

12.1.4. Others

12.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 13. Global AI in Revenue Cycle Management Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2021-2034)

13.1.2. Market Revenue and Forecast, by Component (2021-2034)

13.1.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.1.4. Market Revenue and Forecast, by Application (2021-2034)

13.1.5. Market Revenue and Forecast, by End User (2021-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2021-2034)

13.1.6.2. Market Revenue and Forecast, by Component (2021-2034)

13.1.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.1.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.1.6.5. Market Revenue and Forecast, by End User (2021-2034) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Type (2021-2034)

13.1.7.2. Market Revenue and Forecast, by Component (2021-2034)

13.1.7.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.1.7.4. Market Revenue and Forecast, by Application (2021-2034)

13.1.7.5. Market Revenue and Forecast, by End User (2021-2034)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2021-2034)

13.2.2. Market Revenue and Forecast, by Component (2021-2034)

13.2.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.2.4. Market Revenue and Forecast, by Application (2021-2034) 

13.2.5. Market Revenue and Forecast, by End User (2021-2034) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2021-2034)

13.2.6.2. Market Revenue and Forecast, by Component (2021-2034)

13.2.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.2.7. Market Revenue and Forecast, by Application (2021-2034) 

13.2.8. Market Revenue and Forecast, by End User (2021-2034) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2021-2034)

13.2.9.2. Market Revenue and Forecast, by Component (2021-2034)

13.2.9.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.2.10. Market Revenue and Forecast, by Application (2021-2034)

13.2.11. Market Revenue and Forecast, by End User (2021-2034)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2021-2034)

13.2.12.2. Market Revenue and Forecast, by Component (2021-2034)

13.2.12.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.2.12.4. Market Revenue and Forecast, by Application (2021-2034)

13.2.13. Market Revenue and Forecast, by End User (2021-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2021-2034)

13.2.14.2. Market Revenue and Forecast, by Component (2021-2034)

13.2.14.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.2.14.4. Market Revenue and Forecast, by Application (2021-2034)

13.2.15. Market Revenue and Forecast, by End User (2021-2034)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2021-2034)

13.3.2. Market Revenue and Forecast, by Component (2021-2034)

13.3.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.3.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.5. Market Revenue and Forecast, by End User (2021-2034)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2021-2034)

13.3.6.2. Market Revenue and Forecast, by Component (2021-2034)

13.3.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.3.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.7. Market Revenue and Forecast, by End User (2021-2034)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2021-2034)

13.3.8.2. Market Revenue and Forecast, by Component (2021-2034)

13.3.8.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.3.8.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.9. Market Revenue and Forecast, by End User (2021-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2021-2034)

13.3.10.2. Market Revenue and Forecast, by Component (2021-2034)

13.3.10.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.3.10.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.10.5. Market Revenue and Forecast, by End User (2021-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2021-2034)

13.3.11.2. Market Revenue and Forecast, by Component (2021-2034)

13.3.11.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.3.11.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.11.5. Market Revenue and Forecast, by End User (2021-2034)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2021-2034)

13.4.2. Market Revenue and Forecast, by Component (2021-2034)

13.4.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.4.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.5. Market Revenue and Forecast, by End User (2021-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2021-2034)

13.4.6.2. Market Revenue and Forecast, by Component (2021-2034)

13.4.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.4.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.7. Market Revenue and Forecast, by End User (2021-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2021-2034)

13.4.8.2. Market Revenue and Forecast, by Component (2021-2034)

13.4.8.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.4.8.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.9. Market Revenue and Forecast, by End User (2021-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2021-2034)

13.4.10.2. Market Revenue and Forecast, by Component (2021-2034)

13.4.10.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.4.10.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.10.5. Market Revenue and Forecast, by End User (2021-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2021-2034)

13.4.11.2. Market Revenue and Forecast, by Component (2021-2034)

13.4.11.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.4.11.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.11.5. Market Revenue and Forecast, by End User (2021-2034)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2021-2034)

13.5.2. Market Revenue and Forecast, by Component (2021-2034)

13.5.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.5.4. Market Revenue and Forecast, by Application (2021-2034)

13.5.5. Market Revenue and Forecast, by End User (2021-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2021-2034)

13.5.6.2. Market Revenue and Forecast, by Component (2021-2034)

13.5.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.5.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.5.7. Market Revenue and Forecast, by End User (2021-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2021-2034)

13.5.8.2. Market Revenue and Forecast, by Component (2021-2034)

13.5.8.3. Market Revenue and Forecast, by Deployment Mode (2021-2034)

13.5.8.4. Market Revenue and Forecast, by Application (2021-2034)

13.5.8.5. Market Revenue and Forecast, by End User (2021-2034)

Chapter 14. Company Profiles

14.1. Oracle Cerner

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Epic Systems Corporation

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. GeBBS Healthcare Solutions

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. eClinicalWorks

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. GE Healthcare

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Mckesson Corporation

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Veradigm LLC

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Athenahealth, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Experian Information Solutions, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Quest Diagnostics Incorporated

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client